Inovio Pharmaceuticals
INO
#9186
Rank
NZ$0.18 B
Marketcap
NZ$2.71
Share price
1.24%
Change (1 day)
-24.22%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.18 Million. In 2024 the company made an earning of -NZ$0.18 Billion, an increase over its 2023 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.19 Billion4.69%
2024 -NZ$0.18 Billion-20.03%
2023 -NZ$0.23 Billion-51.56%
2022 -NZ$0.46 Billion-8.26%
2021 -NZ$0.51 Billion95.4%
2020 -NZ$0.26 Billion36.62%
2019 -NZ$0.19 Billion20.19%
2018 -NZ$0.16 Billion10.94%
2017 -NZ$0.15 Billion9.59%
2016 -NZ$0.13 Billion118.9%
2015 -NZ$58.61 Million-10.67%
2014 -NZ$65.61 Million83.32%
2013 -NZ$35.79 Million
2011 -NZ$36.92 Million15.64%
2010 -NZ$31.93 Million37.7%
2009 -NZ$23.19 Million2.19%
2008 -NZ$22.69 Million-14.09%
2007 -NZ$26.41 Million19.12%
2006 -NZ$22.17 Million9.62%
2005 -NZ$20.23 Million5.77%
2004 -NZ$19.12 Million73.08%
2003 -NZ$11.05 Million12.75%
2002 -NZ$9.8 Million
2000 -NZ$14.83 Million53.93%
1999 -NZ$9.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.80 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.27 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.68 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.42 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.35 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.48 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-NZ$4.58 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$0.23 B-230.35%๐Ÿ‡บ๐Ÿ‡ธ USA